IOXAGLATE MEGLUMINE AND IOXAGLAT. Key specifications include special_features: PROVIDES 32% IODINE, primary_container_type: BOTTLE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, total_primary_container_quantity: 12, primary_container_content_quantity: 200.000 MILLILITERS. This product is currently in active production with full OEM support.
This part is cataloged in the Federal Logistics Information System (FLIS) under NSN 6505-01-385-2804, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| special_features | PROVIDES 32% IODINE |
| primary_container_type | BOTTLE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| total_primary_container_quantity | 12 |
| primary_container_content_quantity | 200.000 MILLILITERS |
| active_medicament_medicinal_strength | 39.300 PERCENTAGE, W/V IOXAGLATE MEGLUMINE ACTIVE INGREDIENT AND 19.600 PERCENTAGE, W/V IOXAGLATE SODIUM ACTIVE INGREDIENT |
| NSN | 6505-01-385-2804 |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | BOTTLE |
| TOTAL PRIMARY CONTAINER QUANTITY | 12 |
| PRIMARY CONTAINER CONTENT QUANTITY | 200.000 MILLILITERS |
| SPECIAL FEATURES | PROVIDES 32% IODINE |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 39.300 PERCENTAGE, W/V IOXAGLATE MEGLUMINE ACTIVE INGREDIENT AND 19.600 PERCENTAGE, W/V IOXAGLATE SODIUM ACTIVE INGREDIENT |